SKOLNICK PHIL (Chief Scientific Officer) sold 1.6% of their position (385.00 shares) of OPIANT PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $11.7K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 1/12/2022ACC: 0001385508-22-000021
Officer· Chief Scientific Officer
Since Oct 2018
-385.00
Net shares
Net seller
$11.7K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
385.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−385.00
Price / share
$30.49
Trade value
$11.74K
% of position
1.6%
1/10/2022
24.35K→23.96K
Total
Net shares
−385.00
Net value
-$11.74K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/10/2022 | S · Sale | −385.00 | $30.49 | $11.74K | 1.6% | 24.35K | 23.96K |
| Total | −385.00 | -$11.74K | ||||||
Derivative Transactions0
No derivative transactions reported